Regulator approves first new Alzheimer’s drug in 20 years

NEW YORK: US firm Biogen was in the headlines this morning after regulators ... read more

Biotech Biogen surges on Alzeimers drug approval

MELBOURNE: A biotech has jumped on NASDAQ following approval of a Biogen Inc. ... read more

Ansell names Neil Salmon as new CEO for global group

MELBOURNE: Ansell has named the head of its industrial global business unit Neil ... read more

Macquarie facing ASIC probe into $1.8b Nuix float

SYDNEY: Investment banking giant Macquarie Group is facing further reputational damage from its ... read more